Invitrometrix Company Profile

Background

Overview

Invitrometrix is a biotechnology company specializing in the design and manufacture of multi-well Quartz Crystal Microbalance (QCM) devices. These devices enable real-time, quantitative monitoring of cellular biomechanics, including attachment, mass redistribution, and viscoelasticity, thereby enhancing life science research and drug discovery processes.

Mission and Vision

The company's mission is to improve research and drug discovery outcomes by providing innovative tools that allow for continuous, real-time monitoring of cells in culture. Their vision is to make disease models more reliable, facilitating robust drug discovery approaches.

Primary Area of Focus

Invitrometrix focuses on advancing life science and drug discovery research by offering devices that provide continuous, real-time, quantitative monitoring of cells in culture. Their technology aims to improve disease modeling, enabling more reliable and robust drug discovery approaches.

Industry Significance

By offering a non-invasive, label-free method for monitoring cellular responses, Invitrometrix addresses a critical need in the biotechnology and pharmaceutical industries for more accurate and efficient drug discovery tools. Their technology enhances the understanding of cellular behaviors, leading to more effective therapeutic developments.

Key Strategic Focus

Core Objectives

Enhancing Research Accuracy: Provide tools that enable precise, real-time monitoring of cellular responses to various agents.

Improving Drug Discovery: Facilitate more reliable disease modeling to support robust drug discovery approaches.

Expanding Technological Applications: Develop and refine QCM devices to cater to a broader range of research needs.

Specific Areas of Specialization

Cell Culture Monitoring: Utilize QCM technology to monitor cell health and behavior in culture.

Liver Disease Modeling: Employ QCM devices to model liver diseases such as fibrosis and NASH.

Extracellular Matrix Research: Study the effects of the extracellular matrix on regenerative and disease progression.

Key Technologies Utilized

Quartz Crystal Microbalance (QCM): A sensitive surface sensing technology that detects changes in cellular biomechanics.

Multi-Well Plate Format: Allows for high-throughput experimentation and monitoring.

Primary Markets Targeted

Pharmaceutical Industry: For drug discovery and development.

Biotechnology Sector: For life science research and development.

Academic and Research Institutions: For basic and applied research in cell biology and related fields.

Financials and Funding

Funding History

As of the latest available information, Invitrometrix has not publicly disclosed specific details regarding its funding history, total funds raised, or recent funding rounds. The company operates as a private entity with a small team, indicating potential reliance on private investments or internal funding sources.

Notable Investors

Specific details about notable investors are not publicly available.

Intended Utilization of Capital

While specific plans for capital utilization are not disclosed, it is reasonable to infer that funding would be directed towards:

Product Development: Enhancing existing devices and developing new technologies.

Market Expansion: Increasing market presence and reaching new customer segments.

Operational Scaling: Expanding manufacturing capabilities and operational infrastructure.

Pipeline Development

Key Pipeline Candidates

Invitrometrix's primary product is the Discovery-Q, a multi-well QCM device designed for real-time, multi-day monitoring of cell health and response in vitro. The company is also developing subsequent generations of this device, including:

Invitro-Q: A 24-well multi-well device designed for higher throughput, which will include a software suite of biokinetic signatures generated for specific cells in response to agents.

Multi-Q: A high-throughput device that will allow for 96-well experimentation with larger cell well volumes for long-term, multi-day experimentation.

Stages of Development

Discovery-Q: Commercially available and in use for various research applications.

Invitro-Q and Multi-Q: In development stages, with plans for future commercialization.

Target Conditions

Liver Diseases: Including fibrosis and NASH.

Cell Culture Health: Monitoring cell health and behavior in culture.

Extracellular Matrix Research: Studying the effects of the extracellular matrix on regenerative and disease progression.

Anticipated Milestones

Product Launches: Introduction of Invitro-Q and Multi-Q devices upon completion of development.

Market Adoption: Achieving widespread adoption of these devices in relevant research fields.

Technological Platform and Innovation

Proprietary Technologies

Quartz Crystal Microbalance (QCM): A sensitive surface sensing technology that detects changes in cellular biomechanics.

Multi-Well Plate Format: Allows for high-throughput experimentation and monitoring.

Significant Scientific Methods

Real-Time Monitoring: Continuous, real-time monitoring of cellular responses without the need for labels.

Quantitative Analysis: Providing numerical data on cellular biomechanics, including attachment, mass redistribution, and viscoelasticity.

AI-Driven Capabilities

While specific AI-driven capabilities are not detailed, the development of software suites for biokinetic signatures suggests the integration of advanced data analysis techniques to interpret complex biological data.

Leadership Team

Key Executives

Abiche Dewilde: Chief Scientific Officer.

Berk Akinci: Co-founder and Chief Technology Officer.

Professional Backgrounds

Abiche Dewilde: Serves as the Chief Scientific Officer, leading the scientific direction and research initiatives of the company.

Berk Akinci: As Co-founder and Chief Technology Officer, he oversees the technological development and innovation strategies.

Key Contributions

Abiche Dewilde: Instrumental in guiding the scientific research and ensuring the technological relevance of Invitrometrix's products.

Berk Akinci: Played a pivotal role in the development and commercialization of the Discovery-Q device and its subsequent iterations.

Competitor Profile

Market Insights and Dynamics

The market for life science research tools, particularly those facilitating real-time, quantitative monitoring of cellular responses, is growing. Advancements in biotechnology and an increasing emphasis on precision medicine drive demand for innovative research devices.

Competitor Analysis

Invitrometrix operates in a niche segment of the biotechnology industry, focusing on QCM devices for cell monitoring. While specific competitors are not detailed in the available information, companies offering similar technologies or services in the life science research tools market may pose competition.

Strategic Collaborations and Partnerships

Specific details about strategic collaborations or partnerships are not publicly disclosed.

Operational Insights

Invitrometrix's focus on providing non-invasive, label-free monitoring solutions differentiates it from competitors that may rely on more traditional, invasive, or label-dependent methods. This approach offers advantages in terms of data accuracy and relevance to physiological conditions.

Strategic Opportunities and Future Directions

Strategic Roadmap

Product Development: Continue to innovate and develop new devices, such as Invitro-Q and Multi-Q, to meet the evolving needs of the research community.

Market Expansion: Increase market presence by targeting new customer segments and expanding into additional research areas.

Technological Integration: Integrate advanced data analysis techniques, potentially including AI, to enhance the interpretation of complex biological data.

Future Business Directions